Cortney Caudill
Directeur des opérations chez HALOZYME THERAPEUTICS, INC.
Postes actifs de Cortney Caudill
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Directeur des opérations | - | - |
Historique de carrière de Cortney Caudill
Anciens postes connus de Cortney Caudill
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2019 | 06/01/2023 |
| Corporate Officer/Principal | 06/01/2023 | 01/10/2023 | |
| Baxalta Schweiz AG | Corporate Officer/Principal | 01/04/2014 | 01/02/2016 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
| SAMSUNG BIOLOGICS CO.,LTD. | Corporate Officer/Principal | 01/02/2012 | - |
Formation de Cortney Caudill
| The University of Texas at Austin | Undergraduate Degree |
| Fordham University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
| Corée du Sud | 2 |
| Suisse | 2 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SAMSUNG BIOLOGICS CO.,LTD. | Health Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Baxalta Schweiz AG |
- Bourse
- Insiders
- Cortney Caudill
- Expérience
